Detection of metabolites of tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung cancer smokers' urine

Chinese Journal of Lung Cancer

Volumn 9, Issue 3, 2006, Pages 231-235

  Zhang, Tongmei ^a   Lai, Baitang ^a   Duan, Lianshan ^a   Wang, Xiaojue ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Lung neoplasms; Metabolite; Tobacco specific nitrosamine

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; CARCINOGEN; NITROSAMINE;

AMINO ACID ANALYSIS; AMINO ACID URINE LEVEL; ARTICLE; CANCER RISK; CARCINOGENICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DETOXIFICATION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MASS SPECTROMETRY; METABOLITE; SMOKING;

EID: 33745746061     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. World Health Organization. The tobacco epidemic: a global public health emergency. Tobacco Alert. 1998. http://www.who.int/archives/tobalert/apr96/ fulltext.htm.
2. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol, 1998, 11(6):559-603.
3. Lai BT. The study advance of the tobacco specific nitrosamines in lung cancer. Thorac Tumor Tubercul, 2000, 4(3):225-233.
4. Hoffmann D, Brunnemann KD, Prokopczyk B, et al. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J Toxicol Environ Health, 1994, 41(1):1-52.
5. Carmella SG, Akerkar SA, Richie JP Jr, et al. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol Biomarkers Prev, 1995, 4(6):635-642.
6. Hecht SS, Carmella SG, Ye M, et al. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Cancer Res, 2002, 62(1):129-134.
7. Carmella SG, Akerkar S, Hecht SS. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res, 1993, 53(4):721-724.
8. Hecht SS, Carmella SG, Murphy SE, et al. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med, 1993, 329(21):1543-1546.
9. Parsons WD, Carmella SG, Akerkar S, et al. A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the urine of hospital workers exposed to environmental tobacco smoke. Cancer Epidemiol Biomarkers Prev, 1998, 7(3):257-260.
10. Richie JP Jr, Carmella SG, Muscat JE, et al. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomarkers Prev, 1997, 6(10):783-790.